Hidden Risks and Costs of Maternal/Infant Health that Health Plans Miss
[Sponsored] A new report from ProgenyHealth offers a window into how the business works with…
Hidden Risks and Costs of Maternal/Infant Health that Health Plans Miss
[Sponsored] A new report from ProgenyHealth offers a window into how the business works with commercial and Medicaid plans to close gaps in maternity and NICU care management that traditional programs overlook. The post Hidden Risks and Costs of Maternal/Infant Health that Health Plans Miss appeared first on MedCity News.
Witnessing the Failed Execution of Christa Pike: ‘We Could All Hear Her Breathing’
On Sept. 30, I was one of the seven media witnesses who observed Tennessee fail to execute convicted murderer Christa Pike, the first woman to face the death penalty in the state in almost 200 years. From our previous reporting, each of us had an inkling that the lethal injection process might not go according…
Before Saying Yes to the Medical Test, Know the Risks and Benefits
(Maria Fabrizio for WPLN and KFF Health News) When Lori Baute first learned about precautionary full-body MRI scans, she dismissed the idea. “ I heard Kim Kardashian got one, and some other wealthy people,” Baute said. But at 59, she was worried about her long-term health. She has a family history of cancer, and she’s a…
Current and Historical Public Opinion on Medicare-for-All and Other National Health Plan Proposals
This chart pack summarizes KFF polling data on public opinion on Medicare-for-all and other national health plan proposals. The latest update finds that two-thirds of the public supports Medicare-for-all, while support changes drastically as respondents hear arguments from proponents and critics.
Poll: Cost of Health Care and Gas Top Voters’ Midterm Concerns; Democrats Hold Significant Advantage on Health Care Costs and Cost of Living
Just a month away from the midterm elections, affordability worries continue to top the public’s list of midterm election issues, with health care costs and gas costs tying as the top economic concern, KFF’s new Health Tracking Poll finds. Voters overall trust Democrats more than Republicans to handle the cost of health care and the…
AI: Does Europe Have the Answer?
When health systems are stressed, Martin McKee has been there taking notes. He’s spent four decades studying collapse and recovery — the post-Soviet transition, the 2008 financial crisis, the COVID-19 pandemic. Now, as professor of European public health at the London School of Hygiene and Tropical Medicine and research director of the European Observatory on…
KFF Health Tracking Poll: Health Care Issues in the Lead-Up to the 2026 Midterm Election
With the 2026 midterms about a month away, health care costs remain tied with gas as voters’ top midterm concerns and the Democrats hold a clear edge over the Republicans Party on who voters trust to handle many top electoral issues, including the cost of health care and the cost of living. Two-thirds of U.S….
Time to Stop “Calling it Reimbursement”
By JEFF GOLDSMITH Back during the Jurassic period, at the beginning of my consulting career, senior colleagues at Ernst and Whinney took me to lunch to explain to the newby the facts of life in healthcare finance. The biggest takeaway from that long ago conversation: the entire history of hospital finance was built up on…
Investing in Community Health: A New Model for Safety-Net Healthcare Innovation
Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re structured so that the organizations delivering care on the ground collectively become majority owners of the fund as limited partners. The post Investing in Community Health: A New Model for Safety-Net Healthcare Innovation appeared first on MedCity…
Shionogi Adds to Its Rare Disease Strategy With $2B IntraBio Acquisition
Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi’s second big rare disease move this year, following the acquisition of global rights to an amyotrophic lateral sclerosis drug from Tanabe Pharma. The post Shionogi Adds to…
